Document is current
Any future updates will be listed below
-
Authors
Hu, Dong https://orcid.org/0009-0009-3537-8605
Lyu, Xiaoshuang
Li, Zheqi https://orcid.org/0000-0003-1213-640X
Ekambaram, Prasanna
Dongre, Anushka
Freeman, Tanner
Joy, Marion
Atkinson, Jennifer M.
Brown, Daniel D. https://orcid.org/0000-0002-7410-9514
Cai, Zongyou https://orcid.org/0009-0003-7566-7678
Carleton, Neil M. https://orcid.org/0000-0001-6985-7510
Crentsil, Hannah E.
Little, John 4th https://orcid.org/0000-0003-2034-2684
Kemp, Felicia
Klei, Linda R.
Beecher, Maria
Sperinde, Jeff
Huang, Weidong
Joensuu, Heikki https://orcid.org/0000-0003-0281-2507
Srinivasan, Ashok
Pogue-Geile, Katherine L. https://orcid.org/0000-0002-9855-046X
Wang, Ying
Feng, Huichen
Eli, Lisa D.
Lalani, Alshad S.
Zou, Jian
Tseng, George C. https://orcid.org/0000-0002-5447-1014
Bruno, Tullia C. https://orcid.org/0000-0002-6433-0207
Lee, Adrian V. https://orcid.org/0000-0001-9917-514X
Oesterreich, Steffi https://orcid.org/0000-0002-2537-6923
Wolmark, Norman https://orcid.org/0000-0001-7156-1110
Allegra, Carmen J.
Jacobs, Samuel A.
McAllister-Lucas, Linda M. https://orcid.org/0000-0002-9875-5043
Lucas, Peter C. https://orcid.org/0000-0003-4880-7172
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50-CA116201, P30-CA047904, P30-CA15083, F30-CA2649632, P50-CA116201, P30-CA047904, P30-CA15083)
China Scholarship Council
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32-GM008208, T32-GM008208, T32-GM008208)
Sigrid Juselius Foundation
Breast Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 17 April 2023
Accepted: 4 April 2025
First Online: 27 June 2025
Competing interests
: P.E. declares equity interest (class P unit shares) in Inceptor Bio outside the submitted work. J.S. and W.H. are employees of Monogram Biosciences, Laboratory Corporation of America Holdings. H.J. has a leadership role in Orion Pharma, Neutron Therapeutics and Sartar Therapeutics, has a consulting or advisory role in Orion Pharma and Neutron Therapeutics, has received honoraria for scientific meetings from Deciphera Pharmaceuticals and has equity interest in Orion Pharma and Sartar Therapeutics. L.D.E. is an employee of Puma Biotechnology and has equity interest in Puma Biotechnology. A.S.L. is an employee of Puma Biotechnology and has equity interest in Puma Biotechnology. L.M.M.-L. has equity interest in AMGN and has received speaker compensation from Schrödinger, both outside the submitted work. P.C.L. has equity interest in AMGN outside the submitted work. All other authors declare no competing interests.
